Cargando…

Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis

The purpose of this meta-analysis was to evaluate the efficacy and safety of proton pump inhibitors (PPIs) plus antithrombotic strategy in patients with coronary artery diseases compared with antithrombotic strategy alone. We searched PubMed, EMBASE, Cochrane Library, and Chinese Biomedical Medical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Yao-Sheng, Zhong, Peng-Yu, Ma, Ying, Bai, Nan, Niu, Ying, Wang, Zhi-Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249074/ https://www.ncbi.nlm.nih.gov/pubmed/35512058 http://dx.doi.org/10.1097/FJC.0000000000001284

Ejemplares similares

Antiplatelet agents and proton pump inhibitors – personalizing treatment
por: Lin, Eugene, et al.
Publicado: (2010)

Efficacy and Safety of Very Short-Term Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Zhong, Peng-Yu, et al.
Publicado: (2021)

Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
por: Bassand, Jean-Pierre
Publicado: (2012)

Efficacy and Safety of Short-Term Dual Antiplatelet Therapy in East Asians: A Systematic Review and a Meta-Analysis of Randomized Clinical Trials
por: Ma, Ying, et al.
Publicado: (2022)

Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis
por: Saiyitijiang, Alimila, et al.
Publicado: (2022)

Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi‐database cohort study
por: Douros, Antonios, et al.
Publicado: (2022)

Dental management of patients receiving anticoagulant and/or antiplatelet treatment
por: Mingarro-de-León, Ana, et al.
Publicado: (2014)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Impact of concomitant proton pump inhibitor during oral anticoagulant treatment
por: Lee, K N, et al.
Publicado: (2023)

Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013)

Gastrointestinal endoscopy in patients on anticoagulant therapy and antiplatelet agents
por: Zullo, Angelo, et al.
Publicado: (2017)

Co-prescription of Dual-Antiplatelet Therapy and Proton Pump Inhibitors: Current Guidelines
por: Saven, Hannah, et al.
Publicado: (2022)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
por: ten Berg, Jurriën M, et al.
Publicado: (2001)

Reduction of major gastrointestinal bleeding risk with proton pump inhibitor therapy in patients with atrial fibrillation receiving direct oral anticoagulant
por: Lee, S R, et al.
Publicado: (2023)

Improving use of proton pump inhibitors with dual antiplatelet therapy in patients admitted with acute coronary syndrome
por: Jinadu, Tomilola, et al.
Publicado: (2022)

Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence
por: Dézsi, Csaba András, et al.
Publicado: (2017)

New anticoagulants and antiplatelet agents in perioperative period: Recommendations and controversies!
por: Nair, Abhijit S, et al.
Publicado: (2017)

The Conundrum of Anticoagulation and Antiplatelet Therapy in Spontaneous Coronary Artery Dissection
por: Cordova Sanchez, Andres, et al.
Publicado: (2022)

Low adherence to national guidelines for proton-pump inhibitor prescription in patients receiving combination aspirin and anticoagulation
por: Sharma, Rajani, et al.
Publicado: (2017)

Impact of Proton-pump Inhibitors on the Pharmacodynamic Effect and Clinical Outcomes in Patients Receiving Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: A Propensity Score Analysis
por: Zhu, Pei, et al.
Publicado: (2017)

Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022)

Safety and efficacy of anti-inflammatory therapy in patients with coronary artery disease: a systematic review and meta-analysis
por: Niu, Ying, et al.
Publicado: (2022)

A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines
por: Tsai, Hsin-Hui, et al.
Publicado: (2013)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

Implications of direct oral anticoagulation and antiplatelet therapy in intensive care
por: Willcox, Abbey, et al.
Publicado: (2023)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015)

The Knowledge and Perception of Antiplatelet and Anticoagulant agents among Dentists in Northern Jordan
por: Ibdah, Rasheed K, et al.
Publicado: (2020)

Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion
por: Singh, Pali P., et al.
Publicado: (2021)

EFFECT OF ANTICOAGULATION AND ANTIPLATELET AGENTS ON HYPERCOAGULABILITY STATES IN PATIENTS WITH COVID-19
por: UR, JEANNIE, et al.
Publicado: (2021)

Effects of Preoperative Antiplatelet Agents and Anticoagulants on Total Joint Arthroplasty Outcomes
por: Sumarriva, Gonzalo, et al.
Publicado: (2021)

Anticoagulation and Antiplatelet Agent Resumption Timing following Traumatic Brain Injury
por: Jung, In-Ho, et al.
Publicado: (2023)

Safety of ECT in patients receiving an oral anticoagulant
por: Centanni, Nicolette R., et al.
Publicado: (2021)

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review
por: Sherwood, Matthew W., et al.
Publicado: (2015)

Anticoagulant and Antiplatelet Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease
por: Mischke, Karl, et al.
Publicado: (2012)

Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy
por: Lee, Hyun-Jung, et al.
Publicado: (2021)

The Role of Novel Oral Anticoagulants and Antiplatelet Therapy after Percutaneous Coronary Intervention: Individualizing Therapy to Optimize Outcomes
por: Shlofmitz, Evan, et al.
Publicado: (2019)

Outpatient cervical brachytherapy in the setting of ongoing antiplatelet therapy or oral anticoagulation
por: Valakh, Vladimir, et al.
Publicado: (2018)

Use of anticoagulant or antiplatelet agents is not related to epistaxis in patients undergoing transnasal endoscopy
por: Kobayashi, Yoshiya, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rv4ff3c64ac5o6fm9i94tflhoi